David D'Cruz

Jul 17, 2024 | healio.com | Rob Volansky |Shenaz Bagha |David D'Cruz

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Nightmares and hallucinations may occur at any stage of disease course in patients with systemic lupus erythematosus, according to recent findings.

Jun 24, 2024 | acrjournals.onlinelibrary.wiley.com | Joan T Merrill |Yoshiya Tanaka |David D'Cruz |Karina Vila-Rivera

Supporting Information Filename Description art42926-sup-0001-Disclosureform.pdfPDF document, 478.5 KB Disclosure Form art42926-sup-0002-Supinfo.pdfPDF document, 3.5 MB Appendix S1: Supporting Information

Mar 24, 2023 | lupus.bmj.com | David D'Cruz |Yulia Green |Anne Marie Hammer |Gina Eriksson

SafetyWhen comparing older adults and the overall population, there were no clinically relevant differences in the incidence of AEs or SAEs in the pooled safety analysis population or the incidence of SAEs in BASE (table 2). In the pooled safety analysis population, the most commonly reported SAEs in belimumab-treated older adults were nervous system disorders and vascular disorders.